Tse-Ming Chou1,2, Shih-Pin Chen3,4,5,6,7. 1. Institute of Neuroscience, National Yang-Ming University, Taipei, Taiwan. 2. Interdisciplinary Neuroscience Program, Taiwan International Graduate Program, Academia Sinica, Taipei, Taiwan. 3. Institute of Neuroscience, National Yang-Ming University, Taipei, Taiwan. chensp1977@gmail.com. 4. Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan. chensp1977@gmail.com. 5. Division of Translational Research, Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan. chensp1977@gmail.com. 6. Department of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan. chensp1977@gmail.com. 7. Brain Research Center, National Yang-Ming University, Taipei, Taiwan. chensp1977@gmail.com.
Abstract
PURPOSE OF REVIEW: Chronic migraine (CM) is a recalcitrant subtype of migraine which causes high degrees of disability, poor treatment responses, and frequent recurrences in sufferers. However, the pathophysiological mechanisms underlying the development and chronification of migraine attacks remain incompletely understood. A validated animal model could help to decipher the pathogenic mechanism of the disease, facilitating the development of possible therapeutic strategies for CM. In this review, we aimed to summarize current animal models of CM and discuss the validity of these models. RECENT FINDINGS: Several methods have been available to induce recurrent headache-like behaviors or biochemical changes in rodents, including repeated dural application of inflammatory soup, chronic systemic infusion of nitroglycerin, repeated administration of acute migraine abortive treatment to simulate medication overuse headache, or genetic modification. These models exhibit some features that are believed to be associated with migraine; however, none of the model can recapitulate all the clinical phenotypes found in humans and each has its own weakness. The complex features of CM increase the difficulty of constructing a proper animal model. Nonetheless, currently available models are valid to certain degrees. Future directions might consider simulating the spontaneity and chronicity of migraine by combining known genetic substrates and allostatic loads into the same model.
PURPOSE OF REVIEW: Chronic migraine (CM) is a recalcitrant subtype of migraine which causes high degrees of disability, poor treatment responses, and frequent recurrences in sufferers. However, the pathophysiological mechanisms underlying the development and chronification of migraine attacks remain incompletely understood. A validated animal model could help to decipher the pathogenic mechanism of the disease, facilitating the development of possible therapeutic strategies for CM. In this review, we aimed to summarize current animal models of CM and discuss the validity of these models. RECENT FINDINGS: Several methods have been available to induce recurrent headache-like behaviors or biochemical changes in rodents, including repeated dural application of inflammatory soup, chronic systemic infusion of nitroglycerin, repeated administration of acute migraine abortive treatment to simulate medication overuse headache, or genetic modification. These models exhibit some features that are believed to be associated with migraine; however, none of the model can recapitulate all the clinical phenotypes found in humans and each has its own weakness. The complex features of CM increase the difficulty of constructing a proper animal model. Nonetheless, currently available models are valid to certain degrees. Future directions might consider simulating the spontaneity and chronicity of migraine by combining known genetic substrates and allostatic loads into the same model.
Authors: A Bergerot; P R Holland; S Akerman; T Bartsch; A H Ahn; A MaassenVanDenBrink; U Reuter; C Tassorelli; J Schoenen; D D Mitsikostas; A M J M van den Maagdenberg; P J Goadsby Journal: Eur J Neurosci Date: 2006-09 Impact factor: 3.386
Authors: Jes Olesen; Hans-Christoph Diener; Ingo W Husstedt; Peter J Goadsby; David Hall; Ulrich Meier; Stephane Pollentier; Lynna M Lesko Journal: N Engl J Med Date: 2004-03-11 Impact factor: 91.245
Authors: Katarzyna M Targowska-Duda; Akihiko Ozawa; Zachariah Bertels; Andrea Cippitelli; Jason L Marcus; Hanna K Mielke-Maday; Gilles Zribi; Amanda N Rainey; Brigitte L Kieffer; Amynah A Pradhan; Lawrence Toll Journal: Neuropharmacology Date: 2020-03-06 Impact factor: 5.250
Authors: M Torres-Ferrús; F Ursitti; A Alpuente; F Brunello; D Chiappino; T de Vries; S Di Marco; S Ferlisi; L Guerritore; N Gonzalez-Garcia; A Gonzalez-Martinez; D Khutorov; M Kritsilis; A Kyrou; T Makeeva; A Minguez-Olaondo; L Pilati; A Serrien; O Tsurkalenko; D Van den Abbeele; W S van Hoogstraten; C Lampl Journal: J Headache Pain Date: 2020-04-29 Impact factor: 7.277